Skip to main content

PA To Get $148M From 2nd Wave Of Opioid Settlements

PA To Get $148M From 2nd Wave Of Opioid Settlements

Introduction

The first-year compensation from a second wave of federal court settlements involving the opioid and addiction problem could total up to $148 million in Pennsylvania.

Deals were struck with parties who were suing Teva and Allergan, as well as CVS, Walgreens, and Walmart, alleging that they contributed to the overdose fatalities and opioid addiction problem. These parties included states, cities, municipalities, and other parties.

The Pennsylvania Attorney General's Office's deputy chief attorney general for special litigation stated that funds from the most recent settlements may be disbursed as soon as next year.

The Pennsylvania Opioid Misuse and Addiction Abatement Trust's members were informed by the attorney general that the compensation amounts and schedules are subject to final court approval.

The AG stated that although the state doesn't foresee any issues with securing court permission, that approval is what will really cause the process of those payments to proceed.

The trust is in charge of regulating the state's opioid settlement monies and outlays, and it is run by the board of trustees' 13 members.

National settlements with prescription distributors McKesson, Cardinal Health, and AmerisourceBergen, as well as manufacturer Johnson & Johnson started paying out to state and municipal governments earlier this year.

These settlements will provide Pennsylvania a total payout of $1.07 billion over the course of 18 years. A nationwide settlement with OxyContin manufacturer Purdue Pharma is now on hold until the matter is heard by the US Supreme Court.

The contents of that agreement, which were negotiated and authorized in a bankruptcy court for the pharma company's Chapter 11 reorganization plan, will be scrutinized by the Supreme Court.

Even though they haven't declared bankruptcy, the Sackler family members would be protected from future personal claims by the $6 billion national settlement agreement.

In December, the Supreme Court will hear the case's oral arguments. Payouts to Pennsylvania and other litigating parties may be affected by a ruling. It was anticipated that the Commonwealth will get around $225 million.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!